Prestige Consumer Healthcare
PBH
#3828
Rank
A$4.74 B
Marketcap
A$98.69
Share price
0.47%
Change (1 day)
-27.99%
Change (1 year)

EPS for Prestige Consumer Healthcare (PBH)

EPS in 2025 (TTM): A$6.36

According to Prestige Consumer Healthcare's latest financial reports the company's current EPS (TTM) is A$5.82. In 2024 the company made an earnings per share (EPS) of A$6.16 an increase over its 2023 EPS that were of A-$2.31.

EPS history for Prestige Consumer Healthcare from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A$6.363.12%
2024A$6.16-367.08%
2023A-$2.31-138.33%
2022A$6.0211.7%
2021A$5.3913.6%
2020A$4.74-651.67%
2019A-$0.86-148.78%
2018A$1.76-83.29%
2017A$10.55437.23%
2016A$1.96-34.13%
2015A$2.9852.94%
2014A$1.95-8.11%
2013A$2.12
2011A$1.25

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$15.96 174.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Procter & Gamble
PG
A$9.90 70.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$10.55 81.28%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$1.95-66.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$5.37-7.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
A$8.82 51.48%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
A$0.57-90.15%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$5.40-7.19%๐Ÿ‡ฌ๐Ÿ‡ง UK
Rite Aid
RAD
A-$42.46-829.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
A$1.75-69.95%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel